通过大肠杆菌全细胞生物催化剂从3-甲基氨酸中产生尼古丁酸
Sineenat Sripattanakul1, Piyasiri Chueakwon2, Le Thi Thuy Trinh2
1School of Chemistry, Institute of Science, Suranaree University of Technology, Nakhon Ratchasima 30000, Thailand; Office of Research Administration, Chiang Mai University, Chiang Mai 50200, Thailand.
Enzyme and microbial technology
|June 4, 2025
概括
这项研究开发了一种可持续的生物催化方法,用于从3-甲基里丁中生产尼古丁酸 (尼亚/维生素B3),使用工程化大肠杆菌. 该工艺实现了高产量,为化学合成提供了一个环保的替代方案.
科学领域:
- 生物技术是生物技术.
- 代谢工程是代谢工程.
- 生物催化剂是一种生物催化剂.
背景情况:
- 尼古丁酸 (尼亚/维生素B3) 对新陈代谢至关重要,但传统的合成对环境造成了巨大的负担.
- 需要可持续的生产方法来解决尼亚缺乏和减少化学废物.
研究的目的:
- 为尼古丁酸合成建立一个高效的生物催化路径.
- 使用重组E. coli优化3-甲基胺 (3-MP) 转化为尼古丁酸的生物转化.
主要方法:
- 使用工程E. coli MG1655 RARE细胞共同过度表达西单氧酶 (XMO:XylM和XylA) 和醇脱酶 (XylB).
- 休息细胞被用于将3-MP生物转化为尼古丁酸.
- 反应条件被系统地优化,以最大限度地提高产量和效率.
主要成果:
- 在12小时内实现了有效的生物转化,从9毫米的3-MP到8.28±0.35毫米的尼古丁酸.
- 在尼古丁酸生产中获得了92.0%±3.9%的高产量.
- 证明了工程化大肠杆菌菌株对尼古丁酸合成的有效性.
结论:
- 成功开发了一种简化和可持续的尼古丁酸生产生物催化途径.
- 这种方法为传统的化学合成提供了一个环保的替代方案.
- 这项研究为未来的微生物系统代谢工程奠定了基础,用于增强尼古丁酸生产.
相关概念视频
Products of the Citric Acid Cycle
The cells of most organisms—including plants and animals—obtain usable energy through aerobic respiration, the oxygen-requiring version of cellular respiration. Aerobic respiration consists of four major stages: glycolysis, pyruvate oxidation, the citric acid cycle, and oxidative phosphorylation. The third major stage, the citric acid cycle, is also known as the Krebs cycle or tricarboxylic acid (TCA) cycle.
Biosynthesis in Bacteria
Biosynthesis in bacteria is a fundamental anabolic process that generates essential macromolecules, including proteins, nucleic acids, lipids, and polysaccharides. These macromolecules are critical for cellular growth, replication, and function. The process is tightly regulated and energetically linked to catabolic pathways to ensure optimal resource utilization.Biosynthetic pathways begin with precursor metabolites such as pyruvate, acetyl-CoA, and glucose-6-phosphate derived from glycolysis,...
Production of Organic Acids
Lactic acid, an important organic acid extensively applied in food, pharmaceutical, and biodegradable polymer industries, is primarily produced via microbial fermentation. This method is favored over chemical synthesis due to its environmental sustainability and capacity for enantiomerically pure product formation. Among various microbial processes, the fermentation of starch-based substrates stands out due to the abundance and renewability of raw materials like corn and potatoes.Hydrolysis of...
Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...


